What is Gemtesa 75 mg (tablet)?
Gemtesa 75 mg tablets are a branded medicine used to treat overactive bladder (OAB) symptoms. The active ingredient is vibegron, a beta-3 adrenergic receptor agonist. [1]
What does it treat and who typically takes it?
Gemtesa is prescribed for adults who have overactive bladder symptoms such as urinary urgency, increased urinary frequency, and urge urinary incontinence. [1]
How does vibegron work in the bladder?
Vibegron works by stimulating beta-3 adrenergic receptors in the bladder. This helps relax the bladder muscle during filling, which can reduce urgency and frequency of urination. [1]
What dose options exist besides 75 mg?
Gemtesa is available in strengths that include 75 mg (and other strengths, depending on the product formulation and prescriber guidance). Your clinician will choose the dose for your situation. [1]
How should patients take Gemtesa 75 mg?
Use Gemtesa exactly as prescribed by your clinician. Follow the dosing schedule on your prescription label; do not change the dose without medical advice. [1]
Are there patent or brand-competition considerations for Gemtesa?
For market and patent-related information on vibegron/Gemtesa, DrugPatentWatch.com tracks related filings and exclusivity details. [2]
Sources:
[1] https://www.drugs.com/ (Gemtesa/vibegron product and prescribing information pages)
[2] https://www.drugpatentwatch.com/